Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus.
Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn AV, Virmani R.
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):191-204. doi: 10.1161/ATVBAHA.116.306256. Epub 2016 Dec 1.
Progression of Cerebral Small Vessel Disease Among Neurologically Asymptomatic Middle-Aged Individuals With Type 1 Diabetes.
Tarkkonen A, Kyläheiko I, Inkeri J, Eriksson MI, Thorn LM, Summanen PA, Tatlisumak T, Groop PH, Putaala J, Gordin D, Martola J; FinnDiane Study Group.
Diabetes Care. 2025 May 1;48(5):776-780. doi: 10.2337/dc24-1825.
Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T, Secrest AM, Ferrell RE, Orchard TJ.
Diab Vasc Dis Res. 2014 Sep;11(5):335-42. doi: 10.1177/1479164114539713. Epub 2014 Jul 3.
A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus.
Xu L, Wang W, Song W.
Diabetes Res Clin Pract. 2022 Sep;191:110073. doi: 10.1016/j.diabres.2022.110073. Epub 2022 Sep 6.
Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes.
Eriksson MI, Summanen P, Gordin D, Forsblom C, Shams S, Liebkind R, Tatlisumak T, Putaala J, Groop PH, Martola J, Thorn LM; FinnDiane Study Group.
BMJ Open Diabetes Res Care. 2021 Aug;9(1):e002274. doi: 10.1136/bmjdrc-2021-002274.
Cerebral Small Vessel Disease Is Associated With Smaller Brain Volumes in Adults With Type 1 Diabetes.
Claesson TB, Putaala J, Shams S, Salli E, Gordin D, Mutter S, Tatlisumak T, Groop PH, Martola J, Thorn LM.
J Diabetes Res. 2024 Jul 2;2024:5525213. doi: 10.1155/2024/5525213. eCollection 2024.
Depressive symptoms and cerebral microvascular disease in adults with Type 1 diabetes mellitus.
Nunley KA, Karp JF, Orchard TJ, Costacou T, Aizenstein HJ, Jennings JR, Rosano C.
Diabet Med. 2019 Sep;36(9):1168-1175. doi: 10.1111/dme.13879. Epub 2019 Jan 18.
Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease.
Cai X, Li J, Cai W, Chen C, Ma J, Xie Z, Dong Y, Liu C, Xue R, Zhao J.
J Diabetes Complications. 2021 Apr;35(4):107833. doi: 10.1016/j.jdiacomp.2020.107833. Epub 2021 Jan 2.
Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes.
Inkeri J, Adeshara K, Harjutsalo V, Forsblom C, Liebkind R, Tatlisumak T, Thorn LM, Groop PH, Shams S, Martola J, Putaala J, Gordin D; FinnDiane Study Group.
Acta Diabetol. 2022 Apr;59(4):481-490. doi: 10.1007/s00592-021-01821-8. Epub 2021 Nov 15.
Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.
Pickering J, Wong R, Al-Salami H, Lam V, Takechi R.
Pharm Res. 2021 Sep;38(9):1477-1484. doi: 10.1007/s11095-021-03100-1. Epub 2021 Sep 3.
